Endovascular approachesto acute stroke, part 1: Drugs, devices, and data

American Journal of Neuroradiology

Volumn 30, Issue 4, 2009, Pages 649-661

  Nogueira, R G ^a,b   Schwamm, L H ^b   Hirsch, J A ^a  

^a Neurocritical Care and Vascular Neurology Section   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALFIMEPRASE; ALTEPLASE; ANCROD; ARGATROBAN; DESMOTEPLASE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HIRULOG; LEPIRUDIN; MICROPLASMIN; PLACEBO; PLASMINOGEN ACTIVATOR; PROUROKINASE; RETEPLASE; STREPTOKINASE; TENECTEPLASE; THROMBIN INHIBITOR; TIROFIBAN; UNCLASSIFIED DRUG; UROKINASE; V 10153;

ADJUVANT THERAPY; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BYPASS SURGERY; CATHETER OCCLUSION; CATHETERIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOVASCULAR SURGERY; FIBRINOLYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LOW DRUG DOSE; PERCUTANEOUS THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLASMINOGEN ACTIVATION; REVASCULARIZATION; REVIEW; STENT; SURGICAL EQUIPMENT; SYSTEMIC HYPOFIBRINOGENEMIA; THROMBUS; THROMBUS ASPIRATION; TREATMENT DURATION; ACUTE DISEASE; BRAIN ANGIOGRAPHY; CEREBRAL REVASCULARIZATION; FIBRINOLYTIC THERAPY; METHODOLOGY; STROKE; THROMBECTOMY;

ACUTE DISEASE; CEREBRAL ANGIOGRAPHY; CEREBRAL REVASCULARIZATION; HUMANS; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY;

EID: 64649092596     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1486     Document Type: Review

References (95)

1. Stroke: 1989-recommendations on stroke prevention, diagnosis, and therapy: Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 1989;20:1407-31
2. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics: 2008 update-areportfromtheAmerican Heart AssociationStatisticsCommittee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-146
3. Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. N Engl J Med 1995;333:1581-87
4. Practiceadvisory: thrombolytic therapy for acuteischemic stroke-summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996;47:835-39
5. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke-a statement for healthcare professionals from a Special Writing Group of the Stroke Council.American Heart Associ- ation. Circulation 1996;94:1167-74
6. Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003:CD000213
7. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rtPA stroke trials. Lancet 2004;363:768 -74
8. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29
9. Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator: The rtPA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993;14:3-13
10. Caplan LR, Mohr JP, Kistler JP, et al. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis-not a panacea for ischemic stroke. NEngl J Med 1997;337:1309-10, discussion 1313
11. Haley EC Jr, Lewandowski C, Tilley BC. Myths regarding the NINDS rtPA StrokeTrial: Settingtherecord straight. AnnEmergMed1997;30:676-82
12. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical out comes: Novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol 2004;61:1066-70
13. Kleindorfer D, Lindsell CJ, Brass L, etal. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 2008;39:924-28. Epub 2008 Jan 31
14. Reeves MJ, Arora S, Broderick JP,et al. AcutestrokecareintheUS: Resultsfrom 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 2005;36:1232-40
15. Barnwell SL, Clark WM, Nguyen TT, et al. Safety and efficacy of delayed in- traarterial urokinase therapy with mechanical clot disruption for thrombo- embolic stroke. AJNR Am J Neuroradiol 1994;15:1817-22
16. Lisboa RC, Jovanovic BD, Alberts MJ. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 2002;33: 2866-71
17. Qureshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-doseintra-arterialthird-generation thrombolytic agent for ischemic stroke: A prospective study. Neurosurgery 2002;51:1319-27, discussion 1327-29
18. Cornu C, Boutitie F, Candelise L, etal. Streptokinase in acute ischemic stroke: An individual patient data meta-analysis-TheThrombolysis in Acute Stroke Pooling Project. Stroke 2000;31:1555-60
19. Kaur J, Zhao Z, Klein GM, et al. The neurotoxicity of tissue plasminogen activator? JCereb BloodFlowMetab 2004;24:945-63
20. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke-PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11
21. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study-a randomized controlled trial. Pro- lysein Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11
22. Haley EC Jr, Lyden PD, Johnston KC, et al. A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke 2005;36:607-12
23. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73. Epub 2004 Nov29
24. Furlan AJ, Eyding D, Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227-31
25. Hacke W. Desmoteplase in Acute Ischemic Stroke Trial-2 (DIAS-2). Abstract presentedat: 16thEuropeanStrokeConference; May29-June1, 2007; Glasgow, Scotland
26. Hoh BL, Nogueira RG, O'Donnell J, Pryor JC, et al. Intra-arterial thrombolysis for acute stroke: Comparison of era using urokinase versus era not using urokinase at a single center. Abstract presented at: Seventh Joint Meeting of the AANS/CNS Section on Cerebrovascular Surgery and the American Society of Interventional and Therapeutic Neuroradiology; February 1-4, 2004; San Diego, Calif
27. Eckert B, Kucinski T, Neumaier-Probst E, et al. Local intra-arterial fibrinolysis inacutehemisphericstroke: Effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome. Cerebrovasc Dis 2003;15:258-63
28. Lapchak PA, Araujo DM, Pakola S, et al. Microplasmin: A novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke 2002;33:2279-84
29. Deitcher SR, Toombs CF. Non-clinical and clinical characterizationofanovel acting thrombolytic: Alfimeprasc. Pathophysiol Haemost Thromb 2005;34: 215-20
30. ShermanDG, AtkinsonRP, Chippendale T, etal. Intravenous ancrod for treat- ment of acute ischemic stroke: The STAT study-a randomized controlled trial. StrokeTreatment with Ancrod Trial. JAMA2000;283:2395-403
31. Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke.AJNRAmJNeu- roradiol 2004;25:322-28
32. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology2002;59:862-67
33. Abciximab in acute ischemic stroke: A randomized, double-blind, placebo- controlled, dose-escalationstudy-TheAbciximab in Ischemic Stroke Inves-tigators. Stroke 2000;31:601-09
34. Pancioli AM, Broderick J, Brott T, for the CLEAR Trial Investigators. The combined approach to lysis utilizing eptifibatide and rtPA in acute ischemic stroke: The CLEAR stroke trial. Stroke2008;39:3268-76. Epub2008 Sep 4
35. Adams HP Jr, Effron MB, Torner J, et al. Emergency administration of abcix- imab for treatment of patients with acute ischemic stroke: Results of an inter- national phase III trial-Abciximab inEmergencyTreatmentofStrokeTrial (AbESTT-II). Stroke 2008;39:87-99. Epub 2007 Nov21
36. EckertB, KochC, ThomallaG, etal. Acute basilar art ery occlusion treated with combined intravenous Abciximab and intra-arterial tissue plasminogen activator: Report of3 cases. Stroke 2002;33:1424-27
37. Lee DH, Jo KD, Kim HG, et al. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: A pilot study. J Vasc Interv Radiol 2002;13:769-74
38. Deshmukh VR, Fiorella DJ, Albuquerque FC, et al. Intra-arterial thrombolysis for acute ischemic stroke: Preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy. Neurosurgery 2005;56:46-54, discussion 54-55
39. Nogueira RG, Schwamm LH, Buonanno FS, et al. Low-pressure balloon angio- plasty with adjuvant pharmacological therapy in patients with acute ischemic stroke caused by intracranial arterial occlusions. Neuroradiology 2008;50: 331-40
40. Qureshi AI, Harris-Lane P, Kirmani JF, etal. Intra-arterial reteplase andintra- venous abciximab in patients with acute ischemic stroke: Anopen-label,dose- ranging, phase I study. Neurosurgery 2006;59:789-96, discussion 796-97
41. Mangiafico S, Cellerini M, Nencini P, et al. Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. AJNRAm J Neuroradiol 2005;26:2595-601
42. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plas- minogen activator inacute ischemicstroke: Results ofthe multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177-82
43. NogueiraRG,SmithWS. Safety and efficacy of endo vascular thrombectomy in patients with abnormal hemostasis: Pooled analysis ofthe MERCI and Multi MERCI trials. Stroke. 2009;40:516-22. Epub 2008 Dec 18
44. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embo- lectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 2005;36:1432-38
45. Smith WS, Sung G, Saver J, etal. Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke 2008;39:1205-12. Epub 2008 Feb 28
46. Yu W, Binder D, Foster-Barber A, et al. Endovascular embolectomy of acute basilar artery occlusion. Neurology2003;61:1421-23
47. Ueda T, Hatakeyama T, Kohno K, et al. Endovascular treatment for acute thrombotic occlusion of the middle cerebral artery: Local intra-arterial thrombolysis combined with percutaneous transluminal angioplasty. Neuro- radiology1997;39:99-104
48. Gralla J, Schroth G, Remonda L, et al. Mechanical Thrombectomy for Acute Ischemic Stroke: Thrombus-Device Interaction, Efficiency, and Complications In Vivo. Stroke 2006;37:3019-24. Epub 2006 Oct 19
49. Mayer TE, Hamann GF, Brueckmann H. Mechanical extraction of a basilar- artery embolus with the useo f flow reversal and a microbasket. NEngl JMed 2002;347:769-70
50. Nesbit GM, Luh G, Tien R, et al. New and future endovascular treatment strategies for acute ischemic stroke. JVascIntervRadiol 2004;15:S103-10
51. Bergui M, Stura G, Daniele D, et al. Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first-line treatment. Stroke 2006;37:145-50
52. Chapot R. First experience with the Catch, a new device for cerebral throm- bectomy. InterventNeuroradiol 2005;11(suppl 2):58
53. Brekenfeld C, Schroth G, El-Koussy M, et al. Mechanical thromboembolec- tomyfor acute ischemicstroke: Comparison ofthe catch thrombectomyde- viceand the Merci Retriever in vivo. Stroke 2008;39:1213-19
54. Henkes H JR, Lowens S, Miloslavski E, et al. A device for fast mechanical clot retrieval from intracranial arteries (Phenox clot retriever). Neurocrit Care 2006;5:134-40
55. Liebig T, Reinartz J, Guethe T, et al. Early clinical experiences with a new thrombectomy device for the treatment of ischemic stroke. Stroke2008;39:608
56. Schumacher HC, Meyers PM, Yavagal DR, et al. Endovascular mechanical thrombectomy of an occluded superior division branchofthe left MCA for acute cardioembolic stroke. Cardiovasc Intervent Radiol 2003;26:305-08
57. Henkes H, Lowens S, Preiss H, et al. A new device for endovascular coil retrieval from intracranial vessels: Alligator retrieval device. AJNR Am JNeuro- radiol 2006;27:327-29
58. Kerber CW, Wanke I, Bernard J Jr, et al. Rapid intracranial clot removal with a new device: The alligator retriever. AJNR Am JNeuroradiol 2007;28:860-63
59. Veznedaroglu E, Levy EI. Endovascular management of acute symptomatic intracranial arterial occlusion. Neurosurgery2006;59:S242-50
60. LiebigT, ReinartzJ, Hannes R, etal. Comparative in vitro study of five mechan- ical embolectomy systems: Effectiveness of clot removal and risk of distal em- bolization. Neuroradiology2008;50:43-52
61. Chapot R, Houdart E, Rogopoulos A, et al. Thromboaspiration in the basilar artery: Report oftwo cases. AJNR Am JNeuroradiol 2002;23:282-84
62. BrekenfeldC, RemondaL, NedeltchevK, etal. Endovascularneuroradiological treatment of acute ischemic stroke: Techniques and results in 350 patients. Neurol Res 2005;27(suppl 1):S29-35
63. Lutsep HL, Clark WM, Nesbit GM, et al. Intraarterial suction thrombectomy in acute stroke. AJNR Am JNeuroradiol 2002;23:783-86
64. Bellon RJ, Putman CM, Budzik RF, et al. Rheolytic thrombectomy of the occluded internal carotid artery in the setting of acute ischemic stroke. AJNR Am JNeuroradiol 2001;22:526-30
65. MolinaCA, SaverJL. Extendingreperfusion therapy for acute ischemic stroke: Emerging pharmacological, mechanical, and imaging strategies. Stroke2005;36:2311-20
66. Bose A, Henkes H, Alfke K, et al. The Penumbra System: A mechanical device for the treatment ofacute stroke due to thromboembolism. AJNR Am JNeu- roradiol 2008;29:1409-13. Epub2008 May22
67. KerberCW, Barr JD, BergerRM, et al. Snareretrieval of intracranial thrombus in patients with acute stroke. JVascIntervRadiol 2002;13:1269-74
68. Ueda T, Sakaki S, Nochide I, et al. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 1998;29:2568-74
69. Nakano S, Iseda T, Yoneyama T, et al. Direct percutaneous transluminal an- gioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 2002;33:2872-76
70. Abou-Chebl A, Bajzer CT, Krieger DW, etal. Multimodal therapy for the treat- ment of severe ischemic stroke combining GP IIb/III a antagonists and angio- plasty afterfailure of thrombolysis. Stroke 2005;36:2286-88
71. Berlis A, Lutsep H, Barnwell S, et al. Mechanical thrombolysis in acute isch- emic stroke with endovascular photoacoustic recanalization. Stroke 2004;35: 1112-16. Epub 2004 Mar 11
72. Lutsep H. Mechanical thrombolysis in acute stroke: emedicine. November 2, 2006. Available at: http://emedicine.medscape.com. Accessed December 10, 2008
73. Mahon BR, Nesbit GM, Barnwell SL, et al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am JNeuroradiol 2003;24:534-38
74. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127-35. Epub 2007 May24
75. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. NEngl JMed2004;351:2170-78
76. Lang EV, Kulis AM, Villani M, et al. Hemolysis comparison between the Om- niSonics OmniWave Endovascular System and the Possis AngioJet in a por-cinemodel. JVascIntervRadiol 2008;19:1215-21. Epub 2008 Jun 2
77. Levy EI, Ecker RD, Horowitz MB, et al. Stent-assisted intracranial recanaliza- tion for acute stroke: Earlyresults. Neurosurgery2006;58: 458 -63
78. LevyEI, SauvageauE, HanelRA, etal. Self-expanding versus balloon-mounted stents for vessel recanalization following embolic occlusion in the canine model: Technical feasibility study. AJNR Am JNeuroradiol 2006;27:2069-72
79. Peluso JP, van Rooij WJ, Sluzewski M, et al. A new self-expandable nitinol stent for the treatment of wide-neck aneurysms: initial clinical experience. AJNR Am JNeuroradiol 2008;29:1405-08
80. Lubicz B, Leclerc X, Levivier M, et al. Retractable self-expandable stent for endovascular treatment of wide-necked intracranial aneurysms: Preliminary experience. Neurosurgery2006;58:451-57
81. Yavuz K, Geyik S, Pamuk AG, et al. Immediate and midterm follow-up results of using an electrodetachable, fully retrievable SOLO stent system in the en- dovascular coil occlusion of wide-necked cerebral aneurysms. J Neurosurg 2007;107:49-55
82. Levy EI, Mehta R, Gupta R, et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am JNeuroradiol 2007;28:816-22
83. Zaidat OO, Wolfe T, Hussain SI, et al. Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke 2008;39:2392-95
84. Fitzsimmons BF, Becske T, Nelson PK. Rapid stent-supported revasculariza- tion in acute ischemic stroke. AJNR Am JNeuroradiol 2006;27:1132-34
85. Sauvageau E, Levy EI. Self-expanding stent-assisted middle cerebral artery recanalization: Technical note. Neuroradiology2006;48:405-08
86. Dabus G, NogueiraRG. Empty microcatheter technique for the deployment of a self-expanding stent to treat refractory middle cerebral artery occlusion in the setting of severe proximal tortuosity. J Neuroimaging 2008 Apr 3. [Epub ahead of print]
87. JahanR. Anovel,self expanding, fully retractable mechanical thromboembo- lectomy device for treatment of acute ischemic stroke. Abstract presented at: 5th Annual Meeting of the Society of Neurolnterventional Surgery; July 28- August 1, 2008; Lake Tahoe, Calif.
88. Henkes H, Miloslavski E, Lowens S, et al. Treatment of intracranial atheroscle- rotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology2005;47:222-28
89. Jovin TG, Gupta R, Uchino K, et al. Emergent stenting of extracranial internal carotid artery occlusion in acute stroke has a high revascularization rate. Stroke 2005;36:2426-30
90. Kelly ME, Furlan AJ, Fiorella D. Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial mi- crostent as a temporary endovascular bypass. Stroke 2008;39:1770-73
91. Jovin TG, Gupta R, Horowitz MB, et al. Pretreatment ipsilateral regional cor- tical blood flow influences vessel recanalization in intra-arterial thrombolysis for MCAocclusion. AJNR Am JNeuroradiol 2007;28:164-67
92. JoKD, SaverJL, Starkman S, etal. Predictors of recanalization with mechanical thrombectomy for acute ischemic stroke. Stroke 2008;39:599
93. Mistri AK, Robinson TG, Potter JF. Pressor therapyin acute ischemicstroke: systematic review. Stroke 2006;37:1565-71
94. LylykP, Vila JF, MirandaC, etal. Partial aortic obstruction improves cerebral perfusion and clinical symptoms in patients with symptomatic vasospasm. Neurol Res 2005;27(suppl 1):S129-35
95. Frazee JG, Luo X, Luan G, et al. Retrograde transvenous neuroperfusion: A back door treatment for stroke. Stroke 1998;29:1912-16